College of Life Sciences, Hebei University, Baoding 071002, China.
College of Life Sciences, South China Agricultural University, Guangzhou 510642, China.
Viruses. 2023 Aug 18;15(8):1761. doi: 10.3390/v15081761.
OTUD6A is a deubiquitinase that plays crucial roles in various human diseases. However, the precise regulatory mechanism of OTUD6A remains unclear. In this study, we found that OTUD6A significantly inhibited the production of type I interferon. Consistently, peritoneal macrophages and bone marrow-derived macrophages from mice produced more type I interferon after virus infection compared to cells from WT mice. mice also exhibited increased resistance to lethal HSV-1 and VSV infections, as well as LPS attacks due to decreased inflammatory responses. Mechanistically, mass spectrometry results revealed that UBC13 was an OTUD6A-interacting protein, and the interaction was significantly enhanced after HSV-1 stimulation. Taken together, our findings suggest that OTUD6A plays a crucial role in the innate immune response and may serve as a potential therapeutic target for infectious disease.
OTUD6A 是一种去泛素化酶,在多种人类疾病中发挥着关键作用。然而,OTUD6A 的精确调控机制尚不清楚。在本研究中,我们发现 OTUD6A 显著抑制了 I 型干扰素的产生。一致地,与 WT 小鼠的细胞相比,来自 OTUD6A 敲除小鼠的腹膜巨噬细胞和骨髓来源的巨噬细胞在病毒感染后产生了更多的 I 型干扰素。OTUD6A 敲除小鼠还表现出对致死性 HSV-1 和 VSV 感染以及 LPS 攻击的抵抗力增加,这是由于炎症反应减少所致。从机制上讲,质谱结果表明 UBC13 是 OTUD6A 的相互作用蛋白,并且这种相互作用在 HSV-1 刺激后显著增强。综上所述,我们的研究结果表明 OTUD6A 在先天免疫反应中起着至关重要的作用,可能成为感染性疾病的潜在治疗靶点。